7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Atrial Remodeling D064752 1 associated lipids
Vascular Calcification D061205 1 associated lipids
Angina, Stable D060050 2 associated lipids
Bisphosphonate-Associated Osteonecrosis of the Jaw D059266 1 associated lipids
Osteoporotic Fractures D058866 1 associated lipids
Peripheral Arterial Disease D058729 7 associated lipids
Plaque, Atherosclerotic D058226 7 associated lipids
Peri-Implantitis D057873 1 associated lipids
Primary Myelofibrosis D055728 6 associated lipids
Chronic Periodontitis D055113 1 associated lipids
Osteophyte D054850 2 associated lipids
Hyperphosphatemia D054559 1 associated lipids
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative D054438 1 associated lipids
No-Reflow Phenomenon D054318 2 associated lipids
Acute Coronary Syndrome D054058 11 associated lipids
Hypercalciuria D053565 4 associated lipids
Renal Insufficiency, Chronic D051436 9 associated lipids
Fractures, Bone D050723 4 associated lipids
Arteriolosclerosis D050379 1 associated lipids
Atherosclerosis D050197 85 associated lipids
Dyslipidemias D050171 7 associated lipids
Hashimoto Disease D050031 1 associated lipids
Hyperparathyroidism, Primary D049950 1 associated lipids
Diabetes Complications D048909 4 associated lipids
Hypertension, Pregnancy-Induced D046110 2 associated lipids
Scleroderma, Limited D045745 1 associated lipids
Glucose Metabolism Disorders D044882 3 associated lipids
Malnutrition D044342 6 associated lipids
Irritable Bowel Syndrome D043183 8 associated lipids
Mastocytoma D034801 3 associated lipids
Hearing Loss D034381 3 associated lipids
Pulmonary Disease, Chronic Obstructive D029424 16 associated lipids
Spondylarthropathies D025242 1 associated lipids
Spondylarthritis D025241 1 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Coronary Stenosis D023921 6 associated lipids
Carcinoma, Pancreatic Ductal D021441 6 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Multiple Sclerosis, Chronic Progressive D020528 3 associated lipids
Brain Infarction D020520 17 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Lithiasis D020347 2 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Tooth Ankylosis D020254 1 associated lipids
Venous Thrombosis D020246 11 associated lipids
Intracranial Hemorrhage, Traumatic D020198 1 associated lipids
Sleep Apnea, Obstructive D020181 9 associated lipids
Genetic Predisposition to Disease D020022 24 associated lipids
Hepatitis C, Chronic D019698 12 associated lipids
Hot Flashes D019584 5 associated lipids
Bone Marrow Neoplasms D019046 2 associated lipids
Myositis, Inclusion Body D018979 3 associated lipids
Sepsis D018805 11 associated lipids
Arthralgia D018771 8 associated lipids
Systemic Inflammatory Response Syndrome D018746 4 associated lipids
Breast Neoplasms, Male D018567 1 associated lipids
Bone Demineralization, Pathologic D018488 1 associated lipids
Ventricular Dysfunction, Left D018487 33 associated lipids
Cholesteatoma, Middle Ear D018424 2 associated lipids
Foot Injuries D018409 1 associated lipids
Alphavirus Infections D018354 1 associated lipids
Hemangioma, Capillary D018324 1 associated lipids
Neoplasms, Squamous Cell D018307 1 associated lipids
Carcinoma, Neuroendocrine D018278 2 associated lipids
Carcinoma, Medullary D018276 2 associated lipids
Carcinoma, Lobular D018275 4 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Adrenocortical Adenoma D018246 1 associated lipids
Fibroma, Ossifying D018214 1 associated lipids
Giant Cell Tumor of Bone D018212 1 associated lipids
Lymphangioleiomyomatosis D018192 1 associated lipids
Bone Cysts, Aneurysmal D017824 2 associated lipids
Diabetic Foot D017719 1 associated lipids
Periodontal Attachment Loss D017622 7 associated lipids
Microvascular Angina D017566 2 associated lipids
Aortic Aneurysm, Abdominal D017544 5 associated lipids
Myocardial Ischemia D017202 11 associated lipids
beta-Thalassemia D017086 5 associated lipids
Arthritis, Reactive D016918 3 associated lipids
Carotid Stenosis D016893 15 associated lipids
POEMS Syndrome D016878 1 associated lipids
Pasteurellaceae Infections D016871 2 associated lipids
Bacteroidaceae Infections D016866 2 associated lipids
Leishmaniasis, Cutaneous D016773 6 associated lipids
Diabetes, Gestational D016640 8 associated lipids
Severe Combined Immunodeficiency D016511 1 associated lipids
Peripheral Vascular Diseases D016491 8 associated lipids
Bacteremia D016470 9 associated lipids
Prosthesis-Related Infections D016459 7 associated lipids
Alveolar Bone Loss D016301 10 associated lipids
Fractures, Stress D015775 2 associated lipids
Mammary Neoplasms, Animal D015674 27 associated lipids
Osteoporosis, Postmenopausal D015663 4 associated lipids
HIV Infections D015658 20 associated lipids
Histiocytosis, Non-Langerhans-Cell D015616 4 associated lipids
Hyperostosis D015576 1 associated lipids
Arthritis, Psoriatic D015535 3 associated lipids
Leukemia, Lymphocytic, Chronic, B-Cell D015451 25 associated lipids
Weight Loss D015431 56 associated lipids
Weight Gain D015430 101 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Bjerre M et al. Osteoprotegerin independently predicts mortality in patients with stable coronary artery disease: the CLARICOR trial. 2014 Scand. J. Clin. Lab. Invest. pmid:25026506
Lee HJ et al. Association between polymorphisms in leptin, leptin receptor, and β-adrenergic receptor genes and bone mineral density in postmenopausal Korean women. 2014 Menopause pmid:23760429
Jun AY et al. Tetrahydrofurofuran-type lignans inhibit breast cancer-mediated bone destruction by blocking the vicious cycle between cancer cells, osteoblasts and osteoclasts. 2014 Invest New Drugs pmid:23673814
Kuroyanagi G et al. Suppression by resveratrol of prostaglandin D2-stimulated osteoprotegerin synthesis in osteoblasts. 2014 Prostaglandins Leukot. Essent. Fatty Acids pmid:24813642
Bastos MF et al. Effects of Cachaça, a typical Brazilian alcoholic beverage, on alveolar bone loss and density: a study in peripubertal rats. 2014 Arch. Oral Biol. pmid:24183604
Park K et al. Increased OPG/RANKL ratio in the conditioned medium of soybean-treated osteoblasts suppresses RANKL-induced osteoclast differentiation. 2014 Int. J. Mol. Med. pmid:24248634
El-Hoss J et al. Modulation of endochondral ossification by MEK inhibitors PD0325901 and AZD6244 (Selumetinib). 2014 Bone pmid:24269278
Tang ZL et al. An experimental study addressing the promotion of mandibular defect repair through the intermittent subcutaneous injection of parathyroid hormone. 2014 J. Oral Maxillofac. Surg. pmid:24071373
Zhao H et al. Long-term resveratrol treatment prevents ovariectomy-induced osteopenia in rats without hyperplastic effects on the uterus. 2014 Br. J. Nutr. pmid:24073920
Steffens JP et al. Testosterone regulates bone response to inflammation. 2014 Horm. Metab. Res. pmid:24526374
Puato M et al. Impact of hypertension on vascular remodeling in patients with psoriatic arthritis. 2014 J Hum Hypertens pmid:23842084
Hooshmand S et al. The effect of dried plum on serum levels of receptor activator of NF-κB ligand, osteoprotegerin and sclerostin in osteopenic postmenopausal women: a randomised controlled trial. 2014 Br. J. Nutr. pmid:24780728
Park MK et al. Halofuginone ameliorates autoimmune arthritis in mice by regulating the balance between Th17 and Treg cells and inhibiting osteoclastogenesis. 2014 pmid:24782183
Nakamura M et al. [Cytokine-mediated bone resorption]. 2014 Clin Calcium pmid:24870834
Nakashima T [Coupling and communication between bone cells]. 2014 Clin Calcium pmid:24870836
Shimamura M et al. OPG/RANKL/RANK axis is a critical inflammatory signaling system in ischemic brain in mice. 2014 Proc. Natl. Acad. Sci. U.S.A. pmid:24847069
Ghorbanihaghjo A et al. Osteoprotegerin and soluble receptor activator of nuclear factor-kappa B ligand in exudative age-related macular degeneration. 2014 Acta Med Iran pmid:24901855
Dzgoeva FU et al. [Osteoprotegerin and fibroblast growth factor 23 in the development of cardiovascular events in chronic kidney disease]. 2014 Ter. Arkh. pmid:25095658
Honma M et al. Regulatory mechanisms of RANKL presentation to osteoclast precursors. 2014 Curr Osteoporos Rep pmid:24477414
Lewis JR et al. Elevated osteoprotegerin predicts declining renal function in elderly women: a 10-year prospective cohort study. 2014 Am. J. Nephrol. pmid:24457210
Dumnicka P et al. Osteoprotegerin, trail and osteoprotegerin/trail ratio in patients at early phase of acute pancreatitis. 2014 Folia Med Cracov pmid:25648306
Shi W et al. Osteoprotegerin is up-regulated in pancreatic cancers and correlates with cancer-associated new-onset diabetes. 2014 Biosci Trends pmid:25641178
Ma Y et al. Acetylcholine affects osteocytic MLO-Y4 cells via acetylcholine receptors. 2014 Mol. Cell. Endocrinol. pmid:24508663
Wu H et al. Ginsenoside metabolite compound K attenuates inflammatory responses of adjuvant-induced arthritis rats. 2014 Immunopharmacol Immunotoxicol pmid:24450920
Wang F et al. Association analysis between g.18873C>T and g.27522G>A genetic polymorphisms of OPG and bone mineral density in Chinese postmenopausal women. 2014 Biomed Res Int pmid:25580430
Park YJ et al. Prediction of subclinical atherosclerosis by serum osteoprotegerin in premenopausal women with systemic lupus erythematous: correlation of osteoprotegerin with monocyte chemotactic protein-1. 2014 Lupus pmid:24531425
Chen W et al. Arthritogenic alphaviral infection perturbs osteoblast function and triggers pathologic bone loss. 2014 Proc. Natl. Acad. Sci. U.S.A. pmid:24733914
Ostrowska Z et al. Selected adipose tissue hormones, bone metabolism, osteoprotegerin and receptor activator of nuclear factor-kB ligand in postmenopausal obese women. 2014 Endokrynol Pol pmid:25554611
Hong YY et al. Fibroblasts regulate variable aggressiveness of syndromic keratocystic and non-syndromic odontogenic tumors. 2014 J. Dent. Res. pmid:24972872
Dessein PH et al. Independent relationship of osteoprotegerin concentrations with endothelial activation and carotid atherosclerosis in patients with severe rheumatoid arthritis. 2014 J. Rheumatol. pmid:24488413
Irtiuga OB et al. [Concentration of osteoprotegerin and RANKL in blood serum of patients with aortic stenosis]. 2014 Kardiologiia pmid:25178077
Tella SH and Gallagher JC Prevention and treatment of postmenopausal osteoporosis. 2014 J. Steroid Biochem. Mol. Biol. pmid:24176761
Lenglet S et al. Statin treatment is associated with reduction in serum levels of receptor activator of NF-κB ligand and neutrophil activation in patients with severe carotid stenosis. 2014 Mediators Inflamm. pmid:24648660
Takeshita S et al. Age-related marrow adipogenesis is linked to increased expression of RANKL. 2014 J. Biol. Chem. pmid:24753250
Cardelli M and Aubin JE ERRγ is not required for skeletal development but is a RUNX2-dependent negative regulator of postnatal bone formation in male mice. 2014 PLoS ONE pmid:25313644
Movérare-Skrtic S et al. Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures. 2014 Nat. Med. pmid:25306233
Holt V et al. Identification of a subpopulation of marrow MSC-derived medullary adipocytes that express osteoclast-regulating molecules: marrow adipocytes express osteoclast mediators. 2014 PLoS ONE pmid:25302610
Moran CS et al. Osteoprotegerin deficiency limits angiotensin II-induced aortic dilatation and rupture in the apolipoprotein E-knockout mouse. 2014 Arterioscler. Thromb. Vasc. Biol. pmid:25301844
Schündeln MM et al. Impairment of bone health in pediatric patients with hemolytic anemia. 2014 PLoS ONE pmid:25299063
Nascimento MM et al. Elevated levels of plasma osteoprotegerin are associated with all-cause mortality risk and atherosclerosis in patients with stages 3 to 5 chronic kidney disease. 2014 Braz. J. Med. Biol. Res. pmid:25296363
Kuroyanagi G et al. Down-regulation by resveratrol of basic fibroblast growth factor-stimulated osteoprotegerin synthesis through suppression of Akt in osteoblasts. 2014 Int J Mol Sci pmid:25290095
Brabnikova-Maresova K et al. Serum sclerostin in high-activity adult patients with juvenile idiopathic arthritis. 2014 Arthritis Res. Ther. pmid:25280749
Wohlfahrt JC et al. Sulcus fluid bone marker levels and the outcome of surgical treatment of peri-implantitis. 2014 J. Clin. Periodontol. pmid:24417563
Park SY et al. Betulinic acid, a bioactive pentacyclic triterpenoid, inhibits skeletal-related events induced by breast cancer bone metastases and treatment. 2014 Toxicol. Appl. Pharmacol. pmid:24463094
Davaine JM et al. Osteoprotegerin, pericytes and bone-like vascular calcification are associated with carotid plaque stability. 2014 PLoS ONE pmid:25259713
Wang B et al. Chondrocyte β-catenin signaling regulates postnatal bone remodeling through modulation of osteoclast formation in a murine model. 2014 pmid:24431282
Zhang Z et al. High-dose diosgenin reduces bone loss in ovariectomized rats via attenuation of the RANKL/OPG ratio. 2014 Int J Mol Sci pmid:25257532
Yokota K et al. Combination of tumor necrosis factor α and interleukin-6 induces mouse osteoclast-like cells with bone resorption activity both in vitro and in vivo. 2014 pmid:24431283
Kang JH et al. Osteoprotegerin expressed by osteoclasts: an autoregulator of osteoclastogenesis. 2014 J. Dent. Res. pmid:25256714
Polyzos SA et al. Denosumab treatment for juvenile Paget's disease: results from two adult patients with osteoprotegerin deficiency ("Balkan" mutation in the TNFRSF11B gene). 2014 J. Clin. Endocrinol. Metab. pmid:24433001
Cao H et al. Force-induced Adrb2 in periodontal ligament cells promotes tooth movement. 2014 J. Dent. Res. pmid:25252876
Inanc M et al. Nuclear factor-kappa B ligand and osteoprotegerin levels in serum and gingival crevicular fluid in patients with bone metastases treated with zoledronic acid. 2014 Med. Oncol. pmid:24448976
Prates TP et al. NOD2 contributes to Porphyromonas gingivalis-induced bone resorption. 2014 J. Dent. Res. pmid:25239844
Canalis E et al. Nemo-like kinase regulates postnatal skeletal homeostasis. 2014 J. Cell. Physiol. pmid:24664870
Yamamoto N et al. Regulation by resveratrol of prostaglandin E2-stimulated osteoprotegerin synthesis in osteoblasts. 2014 Int. J. Mol. Med. pmid:25234201
Olivares-Navarrete R et al. Osteoblast lineage cells can discriminate microscale topographic features on titanium-aluminum-vanadium surfaces. 2014 Ann Biomed Eng pmid:25227453
Lee EJ et al. PTX3 stimulates osteoclastogenesis by increasing osteoblast RANKL production. 2014 J. Cell. Physiol. pmid:24664887
Giuliani AL et al. Trophic activity of human P2X7 receptor isoforms A and B in osteosarcoma. 2014 PLoS ONE pmid:25226385
Tao K et al. Influences of IL-6R antibody on PMMA bone cement-mediated expression of OPG and RANKL in synovial fibroblasts. 2014 J. Huazhong Univ. Sci. Technol. Med. Sci. pmid:24710939
Pullisaar H et al. Simvastatin coating of TiOâ‚‚ scaffold induces osteogenic differentiation of human adipose tissue-derived mesenchymal stem cells. 2014 Biochem. Biophys. Res. Commun. pmid:24704451
Chaganti RK et al. Elevation of serum tumor necrosis factor α in patients with periprosthetic osteolysis: a case-control study. 2014 Clin. Orthop. Relat. Res. pmid:24307062
Liu YD et al. Reducing dietary loading decreases mouse temporomandibular joint degradation induced by anterior crossbite prosthesis. 2014 Osteoarthr. Cartil. pmid:24316289
Li T et al. Rabbiteye blueberry prevents osteoporosis in ovariectomized rats. 2014 J Orthop Surg Res pmid:25102951
Kwan JS et al. Meta-analysis of genome-wide association studies identifies two loci associated with circulating osteoprotegerin levels. 2014 Hum. Mol. Genet. pmid:25080503
Yang X et al. [Preliminary study on the best-exerted force chance in the female menstrual cycle]. 2014 Hua Xi Kou Qiang Yi Xue Za Zhi pmid:25033640
Zhou DA et al. Influence of glucocorticoids on the osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. 2014 BMC Musculoskelet Disord pmid:25027542
Rechenberg DK et al. Periapical fluid RANKL and IL-8 are differentially regulated in pulpitis and apical periodontitis. 2014 Cytokine pmid:25022970
Nogueira AV et al. Biomechanical loading modulates proinflammatory and bone resorptive mediators in bacterial-stimulated PDL cells. 2014 Mediators Inflamm. pmid:24976684
Weichhaus M et al. Osteoprotegerin expression in triple-negative breast cancer cells promotes metastasis. 2014 Cancer Med pmid:24976340
Tera Tde M et al. The RANK/ RANKL/ OPG interaction in the repair of autogenous bone grafts in female rats with estrogen deficiency. 2014 Braz Oral Res pmid:25229791
Lis GJ et al. Elevated serum osteoprotegerin is associated with decreased osteoclastic differentiation in stenotic aortic valves. 2014 J. Physiol. Pharmacol. pmid:24930509
Huang C et al. The inhibitory effect of strontium-doped calcium polyphosphate particles on cytokines from macrophages and osteoblasts leading to aseptic loosening in vitro. 2014 Biomed Mater pmid:24518283
Simpson CA et al. Serum levels of sclerostin, Dickkopf-1, and secreted frizzled-related protein-4 are not changed in individuals with high bone mass causing mutations in LRP5. 2014 Osteoporos Int pmid:24927689
Izawa A et al. Inflammatory bone loss in experimental periodontitis induced by Aggregatibacter actinomycetemcomitans in interleukin-1 receptor antagonist knockout mice. 2014 Infect. Immun. pmid:24566623
Fuernau G et al. Growth-differentiation factor 15 and osteoprotegerin in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial. 2014 Eur. J. Heart Fail. pmid:24903195
Knevel R et al. A genetic variant in osteoprotegerin is associated with progression of joint destruction in rheumatoid arthritis. 2014 Arthritis Res. Ther. pmid:24886600
Kyvernitakis I et al. Effect of aromatase inhibition on serum levels of sclerostin and dickkopf-1, bone turnover markers and bone mineral density in women with breast cancer. 2014 J. Cancer Res. Clin. Oncol. pmid:24903965
Zinonos I et al. Pharmacologic inhibition of bone resorption prevents cancer-induced osteolysis but enhances soft tissue metastasis in a mouse model of osteolytic breast cancer. 2014 Int. J. Oncol. pmid:24865346
Todenhöfer T et al. Serum receptor activator of nuclear factor κB ligand (RANKL) levels predict biochemical recurrence in patients undergoing radical prostatectomy. 2014 BJU Int. pmid:23360112
Klimek E et al. Differential associations of inflammatory and endothelial biomarkers with disease activity in rheumatoid arthritis of short duration. 2014 Mediators Inflamm. pmid:24864133
Chen H et al. Runx2 regulates endochondral ossification through control of chondrocyte proliferation and differentiation. 2014 J. Bone Miner. Res. pmid:24862038
Candido R The osteoprotegerin/tumor necrosis factor related apoptosis-inducing ligand axis in the kidney. 2014 Curr. Opin. Nephrol. Hypertens. pmid:24247823
Li B et al. Periodontal ligament stem cells modulate root resorption of human primary teeth via Runx2 regulating RANKL/OPG system. 2014 Stem Cells Dev. pmid:24827498
Khan IS et al. Enhancement of an anti-tumor immune response by transient blockade of central T cell tolerance. 2014 J. Exp. Med. pmid:24752296
Rody WJ et al. Differences in the gingival crevicular fluid composition between adults and adolescents undergoing orthodontic treatment. 2014 Angle Orthod pmid:23687969
Inubushi T et al. Lactoferrin inhibits infection-related osteoclastogenesis without interrupting compressive force-related osteoclastogenesis. 2014 Arch. Oral Biol. pmid:24370195
Huang JW et al. Osteoprotegerin, inflammation and dyslipidemia are associated with abdominal aortic calcification in non-diabetic patients on peritoneal dialysis. 2014 Nutr Metab Cardiovasc Dis pmid:24361071
Jiang XY et al. TNFRSF11B polymorphisms are associated with metabolic traits in Uyghur and Han ethnic groups. 2014 Endocr. Res. pmid:23772656
Ovchinnikova OA et al. The collagen cross-linking enzyme lysyl oxidase is associated with the healing of human atherosclerotic lesions. 2014 J. Intern. Med. pmid:24588843
Montes de Oca A et al. Magnesium inhibits Wnt/β-catenin activity and reverses the osteogenic transformation of vascular smooth muscle cells. 2014 PLoS ONE pmid:24586847
Ostrowska Z et al. Bone metabolism, osteoprotegerin, receptor activator of nuclear factor-κB ligand and selected adipose tissue hormones in girls with anorexia nervosa. 2014 Endokrynol Pol pmid:24549600
Rachner TD et al. Dickkopf-1 is regulated by the mevalonate pathway in breast cancer. 2014 Breast Cancer Res. pmid:24528599
Zanotti S et al. Sex and genetic factors determine osteoblastic differentiation potential of murine bone marrow stromal cells. 2014 PLoS ONE pmid:24489784
Aksu F et al. The relation between the levels of osteoprotegerin and the degree of coronary artery disease in patients with acute coronary syndrome and stable angina pectoris. 2014 Kardiol Pol pmid:24469748
Scialla JJ et al. Biomarkers of vascular calcification and mortality in patients with ESRD. 2014 Clin J Am Soc Nephrol pmid:24458076
Ohba T et al. Bisphosphonates inhibit osteosarcoma-mediated osteolysis via attenuation of tumor expression of MCP-1 and RANKL. 2014 J. Bone Miner. Res. pmid:24443409
Pobeha P et al. Circulatory osteoprotegerin is related to osteoporosis of the hip in patients with COPD. 2014 Respir Med pmid:24424018
Kinney JS et al. Crevicular fluid biomarkers and periodontal disease progression. 2014 J. Clin. Periodontol. pmid:24303954
Chauvat A et al. Clinical validation of IFNγ/IL-10 and IFNγ/IL-2 FluoroSpot assays for the detection of Tr1 T cells and influenza vaccine monitoring in humans. 2014 Hum Vaccin Immunother pmid:24084262
Chaichanasakul T et al. Diverse osteoclastogenesis of bone marrow from mandible versus long bone. 2014 J. Periodontol. pmid:24003963

Table of Content